1. Home
  2. TRVG vs PRLD Comparison

TRVG vs PRLD Comparison

Compare TRVG & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.82

Market Cap

197.0M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

BUY

Current Price

$4.94

Market Cap

218.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TRVG
PRLD
Founded
2005
2016
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
218.0M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
TRVG
PRLD
Price
$2.82
$4.94
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$3.95
$5.67
AVG Volume (30 Days)
23.4K
513.4K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$12,140,000.00
Revenue This Year
$15.59
$320.10
Revenue Next Year
$8.42
$100.00
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
73.43
52 Week Low
$2.59
$0.75
52 Week High
$5.27
$5.54

Technical Indicators

Market Signals
Indicator
TRVG
PRLD
Relative Strength Index (RSI) 53.00 58.58
Support Level $2.77 $1.09
Resistance Level $2.92 $5.54
Average True Range (ATR) 0.06 0.63
MACD 0.01 -0.01
Stochastic Oscillator 54.05 59.26

Price Performance

Historical Comparison
TRVG
PRLD

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: